Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trialYuan Zhang, Luo Zhang, Lijia Wan et al.|EClinicalMedicine|2023Cited by 61
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal PolypsShen Shen, Shui‐Hong Zhou, Bing Yan et al.|JAMA|2025Cited by 23
SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cellsYu Jiang, Yucheng Yang|Clinical Epigenetics|2020Cited by 12
An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trialMu Xian, Luo Zhang, Feng Lan et al.|Nature Communications|2025Cited by 5
[Expert consensus on the prevention and treatment of adverse reactions in subcutaneous immunotherapy(2023, Chongqing)].Yucheng Yang, H B Li, Yu Shen et al.|PubMed|2023Cited by 3